Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.32)
# 2,516
Out of 4,820 analysts
2
Total ratings
50%
Success rate
14.52%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $6.35
Upside: +57.48%